Genentech Asks FDA TO Hold Off Biogenerics Policy Paper
Biotech company Genentech has filed a petition with the U.S. Food and Drug Administration, asking the agency to hold off on the release of its much-anticipated plan for approving generic biological...To view the full article, register now.
Already a subscriber? Click here to view full article